Venner, C. P., LeBlanc, R., Sandhu, I., White, D., Belch, A. R., Reece, D. E., Chen, C., Dolan, S., Lalancette, M., Louzada, M., Kew, A., McCurdy, A., Monteith, B., Reiman, T., McDonald, G., Sherry, M., Gul, E., Chen, B. E., & Hay, A. E. (2021). weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. American journal of hematology, 96(5), 552–560. http://access.bl.uk/ark:/81055/vdc_100127439627.0x000046